Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar

Prestige BioPharma and Dr. Reddy’s Laboratories have signed a binding agreement to commercialise the former’s trastuzumab (HD201) biosimilar in select Latin America and Southeast Asian countries.